Related Experiment Video
Updated: Jun 25, 2025
03:22
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
412
Pulmonary Cryptococcosis: A Diagnostic and Management Challenge Case Report
1Infectious Disease, Edward Via College of Osteopathic Medicine-Carolinas, Spartanburg, USA.
Cureus
|May 31, 2024
Summary
Diagnosing and treating pulmonary cryptococcosis (fungal lung infection) is challenging, as symptoms and imaging often mimic bacterial pneumonia, complicating patient care and requiring further research.
Area of Science:
- Mycology
- Infectious Diseases
- Pulmonology
Background:
- Cryptococcosis is a fungal infection affecting both immunocompromised and immunocompetent individuals.
- Early diagnosis and effective treatment of pulmonary cryptococcosis can be challenging due to non-specific clinical and radiographic presentations.
Observation:
- A 56-year-old female with cirrhosis presented with symptoms mimicking bacterial pneumonia, including abdominal pain, dyspnea, vomiting, and diarrhea.
- Initial antibiotic therapy for presumed bacterial pneumonia was ineffective, prompting further investigation.
Findings:
- Pulmonary cryptococcosis was confirmed via lung biopsy after initial misdiagnosis.
- Antifungal therapy led to adverse effects and limited clinical improvement, highlighting treatment difficulties.
Implications:
- This case underscores the diagnostic and therapeutic challenges posed by pulmonary cryptococcosis.
- Further exploration of optimal diagnostic strategies and management protocols for cryptococcal pneumonia is warranted.
Related Concept Videos
01:28Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
01:24Cystic Fibrosis: Management
154
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
154
01:26Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
01:28Pneumonia IV: Management
322
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
322
01:30Pneumonia III: Complications and Assessment
200
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
200
01:28Pulmonary Tuberculosis II
217
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
217